• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prognostic alternative splicing signature in cervical squamous cell carcinoma.宫颈鳞状细胞癌中预后可变剪接标志物。
IET Syst Biol. 2020 Dec;14(6):314-322. doi: 10.1049/iet-syb.2019.0095.
2
Identification of as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Cervical Squamous Cell Carcinoma.鉴定 为宫颈鳞状细胞癌的潜在预后生物标志物,并与免疫浸润相关。
DNA Cell Biol. 2020 Feb;39(2):255-272. doi: 10.1089/dna.2019.5129. Epub 2020 Jan 24.
3
Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.基于317例样本的剪接序列数据构建膀胱尿路上皮癌可变剪接事件的预后特征
Cell Physiol Biochem. 2018;48(3):1355-1368. doi: 10.1159/000492094. Epub 2018 Jul 26.
4
Characterization of alternative splicing events and prognostic signatures in breast cancer.乳腺癌中可变剪接事件和预后特征的分析。
BMC Cancer. 2021 May 22;21(1):587. doi: 10.1186/s12885-021-08305-6.
5
Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.鉴定与宫颈癌肿瘤免疫微环境相关的坏死性凋亡相关预后基因特征,并进行实验验证。
World J Surg Oncol. 2022 Oct 17;20(1):342. doi: 10.1186/s12957-022-02802-z.
6
A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.基于癌症干性和代谢相关基因的宫颈癌和宫颈内膜腺癌新型预后标志物。
Aging (Albany NY). 2024 Apr 23;16(8):7293-7310. doi: 10.18632/aging.205757.
7
Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma.综合生物信息学结合机器学习分析银屑病和宫颈鳞状细胞癌中的共享生物标志物和通路。
Front Immunol. 2024 May 28;15:1351908. doi: 10.3389/fimmu.2024.1351908. eCollection 2024.
8
A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.基于免疫检查点 HLA-G 驱动的差异表达基因的宫颈癌新型预后风险模型。
Front Immunol. 2022 Jul 18;13:851622. doi: 10.3389/fimmu.2022.851622. eCollection 2022.
9
A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.一种基于七种免疫相关 RNA 的新型预后预测模型,用于预测早期宫颈鳞状细胞癌患者的总生存率。
BMC Med Genomics. 2021 Feb 15;14(1):49. doi: 10.1186/s12920-021-00885-3.
10
Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.可变剪接基因在宫颈鳞状细胞癌和宫颈管腺癌中的预后意义
Int J Gen Med. 2021 Nov 9;14:7933-7949. doi: 10.2147/IJGM.S335475. eCollection 2021.

引用本文的文献

1
Expression Profile of Thymidine Kinase Genes in Cervical Squamous Cell Carcinoma Confirmed by Various Detection Methods.多种检测方法证实的宫颈鳞状细胞癌中胸苷激酶基因的表达谱
World J Oncol. 2025 Feb;16(1):30-50. doi: 10.14740/wjon1962. Epub 2024 Dec 31.
2
A Novel Eight-Gene Signature for Lipid Metabolism Predicts the Progression of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.一种新型的脂质代谢八基因标志物预测宫颈鳞癌和宫颈内膜腺癌的进展。
Reprod Sci. 2024 Feb;31(2):514-531. doi: 10.1007/s43032-023-01364-z. Epub 2023 Sep 25.
3
Competing Endogenous RNA (ceRNA) Networks and Splicing Switches in Cervical Cancer: HPV Oncogenesis, Clinical Significance and Therapeutic Opportunities.宫颈癌中的竞争性内源性RNA(ceRNA)网络与剪接开关:人乳头瘤病毒致癌作用、临床意义及治疗机遇
Microorganisms. 2022 Sep 16;10(9):1852. doi: 10.3390/microorganisms10091852.
4
Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.免疫基因组学鉴定预测宫颈癌患者的预后。
Int J Mol Sci. 2021 Feb 28;22(5):2442. doi: 10.3390/ijms22052442.

本文引用的文献

1
Role of global aberrant alternative splicing events in papillary thyroid cancer prognosis.全球异常可变剪接事件在甲状腺乳头状癌预后中的作用。
Aging (Albany NY). 2019 Apr 15;11(7):2082-2097. doi: 10.18632/aging.101902.
2
Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer.结直肠癌预后性可变剪接特征的全基因组分析
Front Oncol. 2018 Nov 20;8:537. doi: 10.3389/fonc.2018.00537. eCollection 2018.
3
Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculature.结直肠癌脉管系统中可变剪接因子NOVA2的上调
Onco Targets Ther. 2018 Sep 20;11:6049-6056. doi: 10.2147/OTT.S171678. eCollection 2018.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
() is essential for preimplantation embryo development.()对于植入前胚胎发育至关重要。
Biol Open. 2018 Oct 2;7(10):bio035717. doi: 10.1242/bio.035717.
6
Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Gastrointestinal Pan-Adenocarcinomas.系统分析胃肠道胰腺腺癌中与生存相关的可变剪接特征。
EBioMedicine. 2018 Aug;34:46-60. doi: 10.1016/j.ebiom.2018.07.040. Epub 2018 Aug 18.
7
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.对 8705 例肿瘤患者的可变剪接进行全面分析。
Cancer Cell. 2018 Aug 13;34(2):211-224.e6. doi: 10.1016/j.ccell.2018.07.001. Epub 2018 Aug 2.
8
Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.基于317例样本的剪接序列数据构建膀胱尿路上皮癌可变剪接事件的预后特征
Cell Physiol Biochem. 2018;48(3):1355-1368. doi: 10.1159/000492094. Epub 2018 Jul 26.
9
Determination of NF-κB and RANKL levels in peripheral blood osteoclast precursor cells in chronic kidney disease patients.慢性肾病患者外周血破骨细胞前体细胞中NF-κB和RANKL水平的测定
Int Urol Nephrol. 2018 Jun;50(6):1181-1188. doi: 10.1007/s11255-018-1859-0. Epub 2018 Apr 11.
10
NF-κB pathways in the development and progression of colorectal cancer.NF-κB 通路在结直肠癌的发生发展中的作用。
Transl Res. 2018 Jul;197:43-56. doi: 10.1016/j.trsl.2018.02.002. Epub 2018 Mar 1.

宫颈鳞状细胞癌中预后可变剪接标志物。

Prognostic alternative splicing signature in cervical squamous cell carcinoma.

机构信息

Department of Cell Biology and Genetics, School of Pre-clinical Medicine, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.

Department of Pathophysiology, School of Pre-clinical Medicine, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, People's Republic of China.

出版信息

IET Syst Biol. 2020 Dec;14(6):314-322. doi: 10.1049/iet-syb.2019.0095.

DOI:10.1049/iet-syb.2019.0095
PMID:33399095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8687194/
Abstract

Basing on alternative splicing events (ASEs) databases, the authors herein aim to explore potential prognostic biomarkers for cervical squamous cell carcinoma (CESC). mRNA expression profiles and relevant clinical data of 223 patients with CESC were obtained from The Cancer Genome Atlas (TCGA). Correlated genes, ASEs and percent-splice-in (PSI) were downloaded from SpliceSeq, respectively. The PSI values of survival-associated alternative splicing events (SASEs) were used to construct the basis of a prognostic index (PI). A protein-protein interaction (PPI) network of genes related to SASEs was generated by STRING and analysed with Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Consequently, 41,776 ASEs were discovered in 19,724 genes, 2596 of which linked with 3669 SASEs. The PPI network of SASEs related genes revealed that TP53 and UBA52 were core genes. The low-risk group had a longer survival period than high-risk counterparts, both groups being defined according to PI constructed upon the top 20 splicing events or PI on the overall splicing events. The AUC value of ROC reached up to 0.88, demonstrating the prognostic potential of PI in CESC. These findings suggested that ASEs involve in the pathogenesis of CESC and may serve as promising prognostic biomarkers for this female malignancy.

摘要

基于剪接事件(ASEs)数据库,作者旨在探索宫颈癌(CESC)的潜在预后生物标志物。从癌症基因组图谱(TCGA)获得了 223 名 CESC 患者的 mRNA 表达谱和相关临床数据。从 SpliceSeq 分别下载了相关基因、ASE 和百分比剪接(PSI)。使用与生存相关的剪接事件(SASEs)的 PSI 值来构建预后指数(PI)的基础。通过 STRING 生成与 SASEs 相关的基因的蛋白质-蛋白质相互作用(PPI)网络,并通过基因本体论(GO)和京都基因与基因组百科全书(KEGG)进行分析。结果发现,在 19724 个基因中发现了 41776 个 ASE,其中 2596 个与 3669 个 SASE 相关。SASE 相关基因的 PPI 网络表明,TP53 和 UBA52 是核心基因。根据基于前 20 个剪接事件或整体剪接事件的 PI 定义的低风险组比高风险组具有更长的生存期。ROC 的 AUC 值高达 0.88,表明 PI 在 CESC 中的预后潜力。这些发现表明 ASEs 参与了 CESC 的发病机制,可能是这种女性恶性肿瘤有前途的预后生物标志物。